Ranked boards · Editors' Rating · 2026
PCOS, the midlife shift, a first injection and an honest family budget each change what a “good” provider looks like. We scored GLP-1 telehealth on six factors weighted for mothers and built a board for each situation — every one led by our #1 pick, and none of them moved by who pays us.
#1 across every board
The one program on this masthead whose number still makes sense at the top of the dose. A flat, all-in monthly price on both molecules, no teaser rate to expire, and a cancel button you can actually find — the closest thing to a family-budget guarantee we've reviewed.
Grade A · 94/100 — flat, transparent pricing, both molecules on one chart, and all 50 states.
5 ranked boards — pick the one that matches your situation.
The flagship feature — every provider weighed for the way a mother actually lives, with CoreAge Rx first.
See the ranking →When insulin resistance or the midlife shift is driving the weight, tirzepatide access and real oversight matter most.
See the ranking →Starting from scratch — the providers that walk you through the first injection without hiding the price.
See the ranking →The lowest honest cash-pay price that still holds at the maintenance dose — teasers ignored, family budget respected.
See the ranking →When you might have coverage, a brand pen can beat a cheap vial — ranked on who fights the paperwork for you.
See the ranking →Not sure yet? Read every provider review, compare any two head-to-head, or see the full ranking. Rankings reflect our published methodology and never move because a provider pays us — see our funding disclosure.